Integrated Plasma snoRNA–Protein Network Analysis Identifies Circulating Molecular Signatures Associated with High-Risk Benign Breast Lesions and Early Breast Cancer
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27219530 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Mayumi Jijiwa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96813, USA. Hauptthemen laut MEDLINE: RNA, Small Nucleolar, Breast Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of North Texas Health Science Center at Fort Worth, National Institutes of Health, Jean Epstein Foundation Medical Research Grant.
Abstract (Originalsprache)
High-risk benign breast lesions increase subsequent breast cancer risk, yet circulating molecular patterns that distinguish them from early breast cancer remain poorly defined. We profiled plasma small nucleolar RNAs (snoRNAs) and small Cajal body-specific RNAs (scaRNAs) using UMI-based small RNA sequencing in 32 plasma samples from patients with low-risk benign lesions (Be; 9), high-risk benign lesions (HB; 14), or early breast cancer (CA; 9), and integrated matched data-independent acquisition (DIA) proteomics in a subset of 20 samples (HB; 11, CA; 9). Weighted gene co-expression network analysis (WGCNA) of 475 molecular features identified 11 modules. The Yellow module contained 25 snoRNAs/scaRNAs and 26 proteins and was enriched for extracellular matrix (ECM), blood microparticle, platelet, and serine-type endopeptidase inhibitor functions. An exploratory Yellow-module-focused analysis identified 10 snoRNAs with nominally lower abundance in CA than in HB (p < 0.05), showing concordant directions of differential abundance with the global analysis. The strength of differential RNA evidence correlated with mean intramodular RNA–protein correlation (Spearman ρ = 0.788, p = 2.85 × 10−6). External snoDB target mapping supported 28.6% of the exploratory network edges, including SNORD38A–FN1, SNORA73B–LAMB1, SNORD22–LAMB1, and SNORD22–NCAM1. Integration of differential plasma snoRNA profiling, cross-omic network analysis, and experimentally observed snoRNA interaction data indicated convergence on ECM/collagen and platelet/coagulation biology. These candidate snoRNA–protein axes may characterize differences in the circulating molecular states of CA and HB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96813, USA.
- Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD 21218, USA.
ORCID-Profile: Mayumi Jijiwa, Vedbar S Khadka, Matthew Huo, Lauren Higa, Shaina Young, Youping Deng
Förderung
- University of North Texas Health Science Center at Fort Worth
- National Institutes of Health
- Jean Epstein Foundation Medical Research Grant
- Chun Foundation Medical Research Grant
Zitieren
APA
Jijiwa, M., Khadka, V. S., Huo, M., Higa, L., Young, S., & Deng, Y. (2026). Integrated Plasma snoRNA–Protein Network Analysis Identifies Circulating Molecular Signatures Associated with High-Risk Benign Breast Lesions and Early Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219530
Vancouver
Jijiwa M, Khadka VS, Huo M, Higa L, Young S, Deng Y. Integrated Plasma snoRNA–Protein Network Analysis Identifies Circulating Molecular Signatures Associated with High-Risk Benign Breast Lesions and Early Breast Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219530
BibTeX
@article{Jijiwa2026,
author = {Jijiwa, Mayumi and Khadka, Vedbar S and Huo, Matthew and Higa, Lauren and Young, Shaina and Deng, Youping},
title = {Integrated Plasma snoRNA–Protein Network Analysis Identifies Circulating Molecular Signatures Associated with High-Risk Benign Breast Lesions and Early Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27219530}
}
EUVIMED